US 12351644
Anti-CD73 antibodies
granted A61KA61K2039/505A61P
Quick answer
US patent 12351644 (Anti-CD73 antibodies) held by Corvus Pharmaceuticals, Inc. expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corvus Pharmaceuticals, Inc.
- Grant date
- Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00